Filter
143
Text search:
generics
Featured
Recommendations
14
New Publications
39
Language
Document type
No document type
65
Studies & Reports
43
Guidelines
22
Strategic & Response Plan
6
Manuals
4
Situation Updates
2
Infographics
1
Countries / Regions
Global
10
India
5
Kenya
5
Ghana
4
South Africa
4
Ukraine
4
Philippines
3
Tanzania
3
Namibia
3
Sierra Leone
2
Nigeria
2
Senegal
2
Ethiopia
2
Uganda
2
Haiti
2
Rwanda
2
Indonesia
2
Malawi
2
Lesotho
2
Latin America and the Carribbean
2
Western and Central Europe
2
Burkina Faso
1
Zimbabwe
1
Germany
1
Syria
1
Eswatini/ Swaziland
1
Brazil
1
Botswana
1
Myanmar / Burma
1
East and Southern Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Albania
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
55
Clinical Guidelines
20
Public Health
10
Pharmacy & Technologies
9
Women & Child Health
2
Toolboxes
Pharmacy
22
HIV
21
AMR
19
NCDs
12
TB
5
COVID-19
5
Mental Health
3
Global Health Education
3
Health Financing Toolbox
3
Conflict
2
Refugee
2
Planetary Health
2
Examining the infrastructure of the Russian and USA healthcare systems with respect to the management of HIV patients
An analysis from the perspective of the health sector in Latin America and the Caribbean
Washington, D.C., 2017
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities
...
Effective implementation of WHO PEN, combined with other very cost effective population-wide interventions, will help even resource constrained settings to attain the global voluntary targets related to reduction of premature mortality and preventionof heart attacks and strokes.
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I
...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea
...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
Cancer
recommended
This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte
...
During this work, a survey on essential medicines availability was conducted. This article was first written on this subject for sharing the poor financial availability of the essential medicines in the hospital and secondly, a call for an action to be taken in improving hospital pharmacies developm
...
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
